varenicline tartrate (CHANTIX) (Tablet) 1 mg/1

Varenicline tartrate (CHANTIX) 1 mg tablet is a prescription medication used to support smoking cessation. It works by reducing nicotine cravings and withdrawal symptoms. This 1 mg strength tablet is commonly prescribed as part of a quit-smoking plan. Always consult a healthcare provider before use.

Strength

1 mg/1

Manufacturer / TM Owner

Aphena Pharma Solutions - Tennessee, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Varenicline tartrate (CHANTIX) is primarily used to help people stop smoking by reducing cravings and withdrawal symptoms. It is often prescribed as part of a structured smoking cessation program. The medication is designed to ease the transition away from nicotine dependence.

Side Effects

Varenicline tartrate (CHANTIX) may help reduce the urge to smoke and ease withdrawal symptoms like irritability or restlessness. Some users report changes in mood or sleep patterns. These effects vary by individual and are part of the medication’s intended action.

Precautions & Warnings

Keep varenicline tartrate (CHANTIX) in a secure place away from children and pets. Store at room temperature, away from moisture and heat. If you experience unusual changes in mood or behavior, contact a healthcare provider promptly. Do not start or stop this medication without medical guidance.

Avoid Interactions

Varenicline tartrate (CHANTIX) may interact with certain medications, including alcohol and some antidepressants. Combining it with alcohol can increase the risk of side effects. Always inform your healthcare provider about all medications and supplements you are taking before starting varenicline.

Frequently Asked Questions

Varenicline tartrate (CHANTIX) is used to help people stop smoking by reducing cravings and withdrawal symptoms.

Effects on cravings may begin within the first week, but full benefits are typically seen over several weeks of consistent use.

Alcohol may increase the risk of side effects; consult your healthcare provider before consuming alcohol while taking this medication.

It may not be suitable for individuals with certain medical conditions; a healthcare provider should assess suitability before use.

If you miss a dose, take it as soon as you remember, unless it is close to the next scheduled dose; do not double up.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.